![Andrew King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 7 M $ in data 30/09/2026
Dr. Andrew King is a President-Research & Development at Jade Biosciences, Inc. and a Chief Scientific Officer at Jade Biosciences, Inc. (United States).
Dr. King was previously employed as a Chief Scientific Officer by Chinook Therapeutics, Inc. and a Senior Director-Discovery & Translational Biology by Ardelyx, Inc. He received his undergraduate degree from Murdoch University and a doctorate degree from Michigan State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 15/03/2026 | 529.530 ( 0,83% ) | 7 M $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| JADE BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 28/04/2025 |
| Società | Posizione | Fine |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 09/08/2023 |
| ARDELYX, INC. | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Murdoch University
 Murdoch University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes medicines for kidney diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
